Desk
Coverage tied to Anthropic and Claude.
Palisade’s frominside.ai interviews put lab researchers on camera with extinction odds from ~10% to coin-flip — and no single playbook.
Anthropic’s circulated S-1 spends heavily on risk factors—including existential harm—while backers eye a valuation north of $2 trillion.
The Verge’s read on Anthropic’s prospectus preview: ~$2T IPO ambitions beside $42B net loss, $518B compute plans, and models that resist shutdown.
TechCrunch digests the FT and Reuters S-1 leaks: grim model behaviors, existential-risk language, and a growth curve that still seduces a $2T listing dream.
Anthropic’s Sonnet 5.5 lands as a faster, thriftier mid-tier workhorse—about 30% quicker, with cyber safeguards usually reserved for higher tiers.
MIT Tech Review pushes back on Anthropic’s “first discovery” claim for a Claude-driven biology lab—pattern-finding isn’t the hard part of science.
TechCrunch previews a Disrupt 2026 session where Anthropic’s Cat de Jong, Gamma’s Grant Lee, and Clay dig into what happens after the AI demo ends.
Amodei’s first one-on-one with Trump lands the same weekend SNL roasted him—and after months of safety friction with the White House.
Equity’s take on Muse is sharper than the Connect keynote: party tricks land; handing Meta your cards and inbox is the real wall.
SNL turns Amodei’s doom-laden press tour into Gollum comedy—proof that AI safety talk has left the lab and entered late-night folklore.
A 2-1 D.C. Circuit panel let the Pentagon keep Anthropic blacklisted for withholding Claude features—no bad motive required under the broader supply-chain statute.
Anthropic’s $11.6B seven-year Akamai cloud deal bets on CPUs, not just GPUs—and flips the usual circular AI finance with warrants that grow as Anthropic spends.